Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist
- 31 March 2006
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 43 (7) , 891-896
- https://doi.org/10.1016/j.molimm.2005.06.045
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- CRP or not CRP? That Is the QuestionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthaseMedical Hypotheses, 2004
- CRP after 2004Molecular Immunology, 2004
- Interaction of Calcium-bound C-reactive Protein with Fibronectin Is Controlled by pHJournal of Biological Chemistry, 2004
- Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitorsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoterMolecular Immunology, 2003
- Fibrates down-regulate IL-1–stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB–C/EBP-β complex formationBlood, 2003
- Inducible Nitric Oxide Synthase Expression and Erythropoietin Production in Human Hepatocellular Carcinoma CellsBiochemical and Biophysical Research Communications, 1997
- Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.The Journal of Experimental Medicine, 1978